Are Neuropsychological Impairments in Children with Early-Treated Phenylketonuria (PKU) Related to White Matter Abnormalities or Elevated Phenylalanine Levels?

Peter J. Anderson Critical Care and Neurosciences, Murdoch Childrens Research Institute, Australia; Department of Psychology, University of Melbourne, Victoria, Australia

Stephen J. Wood Melbourne Neuropsychiatry Centre, Victoria, Australia; Department of Psychiatry, University of Melbourne, Victoria, Australia

Dorothy E. Francis Metabolic Service, Royal Children's Hospital, Australia; Genetic Health Services of Victoria, Victoria, Australia

Lee Coleman Department of Radiology, Royal Children's Hospital, Melbourne, Australia

Vicki Anderson Critical Care and Neurosciences, Murdoch Childrens Research Institute, Australia; Department of Psychology, University of Melbourne, Victoria, Australia; Department of Psychology, Royal Children's Hospital, Melbourne

Avihu Boneh Critical Care and Neurosciences, Murdoch Childrens Research Institute, Australia; Metabolic Service, Royal Children's Hospital, Australia; Genetic Health Services of Victoria, Victoria, Australia

Are Neuropsychological Impairments in Children with Early-Treated Phenylketonuria (PKU) Related to White Matter Abnormalities or Elevated Phenylalanine Levels?

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Are Neuropsychological Impairments in Children with Early-Treated Phenylketonuria (PKU) Related to White Matter Abnormalities or Elevated Phenylalanine Levels?

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date